Sorafenib Gastric Cancer Asian Phase I Study

Summary

This study is to investigate safety, pharmacokinetics and preliminary efficacy profile of sorafenib in combination with S-1 plus cisplatin in Asian patients with unresectable / recurrent gastric cancer.

Timeline

Start

2008-05

Primary completion

2010-03

Completion

2010-04

Drugs

Indications